InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Gary W Pace, Director, is a corporate insider tracked by InsiderTape across 2 companies. The public record shows 14 open-market SEC Form 4 transactions: 8 purchases worth $3.1M and 6 sales worth $5.9M, reported from Sep 21, 21 to Jul 14, 26. Over this period they have been a mix of buying and selling.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 14, 26 | CRDFCardiff Oncology, Inc. | BUY | 687.3K | $1.46 | $1.0M |
| Jun 18, 26 | CRDFCardiff Oncology, Inc. | BUY | 30.0K | $1.22 | $37K |
| Jul 30, 25 | CRDFCardiff Oncology, Inc. | BUY | 275.0K | $2.45 | $674K |
| Dec 11, 24 | CRDFCardiff Oncology, Inc. | BUY | 350.1K | $2.60 | $910K |
| Mar 8, 24 | PCRXPacira BioSciences, Inc. | SELL | 90.0K | $30.60 | $2.8M |
| Mar 7, 24 | PCRXPacira BioSciences, Inc. | SELL | 28.3K | $30.81 | $871K |
| Mar 6, 24 | PCRXPacira BioSciences, Inc. | SELL | 1.1K | $29.67 | $32K |
| Dec 19, 23 | CRDFCardiff Oncology, Inc. | BUY | 30.0K | $1.37 | $41K |
| Nov 10, 23 | CRDFCardiff Oncology, Inc. | BUY | 22.9K | $0.98 | $22K |
| May 11, 23 | PCRXPacira BioSciences, Inc. | SELL | 5.0K | $41.78 | $210K |
| Sep 15, 22 | CRDFCardiff Oncology, Inc. | BUY | 150.0K | $1.71 | $257K |
| Mar 1, 22 | PCRXPacira BioSciences, Inc. | SELL | 1.4K | $67.75 | $92K |
| Feb 28, 22 | PCRXPacira BioSciences, Inc. | SELL | 28.6K | $66.83 | $1.9M |
| Sep 21, 21 | CRDFCardiff Oncology, Inc. | BUY | 30.0K | $6.75 | $203K |